Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuation Riluzole in the Prevention of Relapse Following Ketamine in Major Depression

NCT00419003 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00419003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00419003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuation Riluzole in the Prevention of Relapse Following Ketamine in Major Depression
Lead sponsor
Baylor College of Medicine
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2006
Completion date
September 30, 2008
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression